The Alloimmunogenicity of Liver Specific Antigen

贾长库,郑树森,万云乐,赵志成,尉建锋,施邵华,谢海洋,蒋国平,宋朋红
DOI: https://doi.org/10.3760/cma.j.issn.0254-1785.2002.06.012
2002-01-01
Abstract:Objective To investigate the alloimmunogenicity of liver specific antigen and its significance. Methods Liver specific antigen isolated from inbred F344 rats was used as immunogen to immunize inbred Lew rats through different immunization pathways such as low-dose long-term hindfoot pads, high-dose portal vein and thymus immunization. Rats receiving 150?mg/kg cyclophosphamide by intraperitoneal route were used as positive control of lymphocyte apoptosis. Mixed lymphocyte culture, mixed lymphocyte hepatocyte culture, Western blotting, DNA gel electrophoresis and TUNEL were employed to analyze the status of peripheral and central lymphoid organs. Results At the time points of sampling, varying degrees of specific low immunoresponses appeared in all immunized groups as well as CY treated group. Compared with groupⅠ, MLC of the experimental groups had no significant changes except that of group Ⅴ, whereas MLHC decreased remarkblely. In all experimental groups, the expression levels of Caspase-3 were increased significantly, splenocytes indicated specific lymphocyte clone apoptosis, and apoptotic cells were also detected in thymus. Conclusions Liver specific antigen has alloimmunogenicity. It may be an important transplantation antigen which may lead to a novel way to liver transplantation immunotolerance. Attempts to modulate immunogenicity of liver allografts or grafted hepatocytes should be direct not only toward the allogenic MHC antigens but also toward allogenic non-MHC antigens.
What problem does this paper attempt to address?